.Merck beats revenues expectations, rears sales overview on powerful requirement for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Forecasts as Keytruda Sales Rise BloombergMerck Stock: Pharma Giant Posts Powerful Outcomes, Yet Expectation Falls Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats profit as well as purchases requirements surrounded by Keytruda strength, but provides mixed full-year outlook MarketWatch.